‘No safety concerns in preventive drug recommended to be taken twice a year’ New Delhi: An HIV-preventive drug showed 100% efficacy and “no safety concerns” in women, according to a study published in The New England Journal of Medicine. Lenacapavir, injectable twice a year, is developed by the US-based biopharmaceutical company Gilead Sciences, Inc as […]